Entecavir Suppliers & Bulk Manufacturers
Available Forms: Tablet
Available Strengths: 0.5 mg, 1 mg
Reference Brands: Baraclude® (EU & US)
Category:
Hepatitis
Entecavir Tablets (Baraclude® generic) are oral antivirals used for chronic hepatitis B. Available in 0.5 mg and 1 mg strengths, manufactured under EU-GMP/USFDA standards. Ideal for B2B supply, licensing, and public health tenders with full CTD support.
Entecavir is available in Tablet
and strengths such as 0.5 mg, 1 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Entecavir is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Entecavir can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Entecavir Tablets (Baraclude® generic) are oral antivirals used to treat chronic hepatitis B infections. Available in 0.5 mg and 1 mg strengths, they inhibit HBV polymerase to reduce viral replication. Manufactured under EU-GMP and USFDA-certified facilities, Entecavir is offered for B2B supply, licensing, and government tenders. The product comes with full CTD dossiers, stability data, and regulatory support. Widely accepted in the US and EU markets, Entecavir is a key product for public health tenders and antiviral portfolios focused on hepatitis B control programs.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing